Author

Rashmi J. Hemani

Observed names: Rashmi Hemani, Rashmi J Hemani

Institutions: Muljibhai Patel Urological Hospital, Charotar University of Science and Technology

Observed institutions: Muljibhai Patel Urological Hospital, Charotar University of Science and Technology

ORCID: 0000-0003-1428-6831

Observed ORCID: 0000-0003-1428-6831

OpenAlex ID: A5113331800

A systematic review and meta-analysis recite the efficacy of Tacrolimus treatment in renal transplant patients in association with genetic variants of CYP3A5 gene.

2023 · Priyal M Chauhan, Rashmi J Hemani, et al. · PubMed · 11

Optimizing tacrolimus dosage in post-renal transplantation using DoseOptimal framework: profiling CYP3A5 genetic variants for interpretability

2025 · Chintal Upendra Raval, Ashwin Makwana, et al. · International Journal of Clinical Pharmacy · 5

Synergistic Effect of Cytochrome P450 Family 3 Subfamily A Member 5 (CYP3A5) Genetic Variants in Tacrolimus Dose Determination in Indian Renal Transplant Patients

2024 · Rashmi J. Hemani, Priyal M. Chauhan, et al. · ACS Pharmacology & Translational Science · 3

Association of Human Leucocyte Antigen with Tacrolimus Pharmacokinetics in Renal Transplant Patients

2026 · Rashmi J. Hemani, Amit S. Joreja, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

Correction: Optimizing tacrolimus dosage in post‑renal transplantation using DoseOptimal framework: profiling CYP3A5 genetic variants for interpretability

2025 · Chintal Upendra Raval, Ashwin Makwana, et al. · International Journal of Clinical Pharmacy

Works count: 5

Citation count: 19

H-index: 3

I10-index: 1